110 likes | 122 Views
According to the latest report by IMARC Group: the global natural killer cells therapeutics market exhibited strong growth during 2015-2020. <br>To learn more about this market, visit us at:<br>https://www.imarcgroup.com/natural-killer-cells-therapeutics-market <br>We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.<br><br>For more information, request for a free sample report here: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample<br>
E N D
Global Natural Killer Cells Therapeutics Market Research and Upcoming Forecast Report Author: Elena Anderson, Marketing Manager | IMARC Group © 2019 IMARC All Rights Reserved Copyright © IMARC Service Pvt Ltd. All Rights Reserved
About IMARC Group Report Description International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and region.The s to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Natural Killer Cells Therapeutics Market Outlook 2026: According to the latest report by IMARC Group, titled “Natural Killer Cells Therapeutics Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, the global natural killer cells therapeutics market exhibited strong growth during 2015-2020. Natural killer (NK) cells are large granular lymphocytes responsible for producing immunoregulatory cytokines. They are a type of white blood cells that act as a vital component of the human immune system. They contain small granules of special proteins such as proteases and perforin known as granzymes. NK cell therapeutics are developed through ex vivo pre-conditioning with cytokine or small molecular drugs and chimeric antigen receptor (CAR) NK. They aim at pathogenic antigens with cytotoxicity and reduce the risk of cytokine storms. Request for a PDF sample of this report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample
Report Description and Highlights Report Description Global Natural Killer Cells Therapeutics Market Trends: The global NK cells therapeutics market is primarily driven by their increasing utilization in various molecular and combination therapies for various treatments. They are used as effective therapeutic drugs in cases of cancer, liver and infectious diseases. Furthermore, the rising awareness regarding the importance of immunotherapies has increased the need for better therapeutic options and the launch of new products, which is expected to influence market growth in the future. As a result, several research activities have resulted in the development of allogeneic NK cells with maximum therapeutic effects. They also enhance the target and extend the persistence of potent immune cells, which helps create a strong and sustained anti-cancer immune-mediated attack. Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026.
Report Description and Highlights Report Description • Key Market Segmentation: • Breakup by Therapeutics: • NK Cell Therapies • NK Cell Directed Antibodies • Breakup by Application: • Cancer • Gastrointestinal Diseases • Immunoproliferative Disorders • Others • Breakup by End User: • Hospitals • Research Centers and Institutes • Others
Report Description and Highlights Report Description • Breakup by Region: • North America • Asia Pacific • Europe • Latin America • Middle East and Africa • Note: We are updating our research report 2021-2026. If you want to need latest primary and secondary data with Cost Module, Business Strategy, Distribution Channel, etc
Report Description and Highlights Report Description • Competitive Landscape: • Affimed GmbH • Bristol-Myers Squibb Company • Fate Therapeutics • Fortress Biotech Inc. • Glycostem Therapeutics • Innate Pharma S.A. • Kuur Therapeutics Inc • Athenex Inc • Nkarta Inc. • Takeda Pharmaceutical Company Limited • Ziopharm Oncology Inc. • View Report TOC, Figures and Tables: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market
Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com